Computational Chemistry Pharmaceuticals Protein Expression Treatment 
Drug Discovery World
NOVEMBER 8, 2023
Presentations that follow include: Andres Perez Bay, PhD, Senior Staff Scientist, Oncology & Angiogenesis, Regeneron Pharmaceuticals, on: ‘A bispecific METxMET antibody-drug conjugate with cleavable linker is processed in recycling and late endosomes’.
Drug Discovery World
SEPTEMBER 5, 2022
Modulations in protein expression levels or the presence of dysfunctional proteins observed in individuals with specific mutations act as biomarkers in selecting patients for targeted therapies. . When selecting patients for therapy, we currently look at variants that directly affect protein expression or function.
Expert insights. Personalized for you.
162 
Let's personalize your content